BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 16125529)

  • 21. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy.
    Annamalai AK; Webb A; Kandasamy N; Elkhawad M; Moir S; Khan F; Maki-Petaja K; Gayton EL; Strey CH; O'Toole S; Ariyaratnam S; Halsall DJ; Chaudhry AN; Berman L; Scoffings DJ; Antoun NM; Dutka DP; Wilkinson IB; Shneerson JM; Pickard JD; Simpson HL; Gurnell M
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1040-50. PubMed ID: 23393175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Petretta M; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 May; 84(5):1518-23. PubMed ID: 10323372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
    Pivonello R; Galderisi M; Auriemma RS; De Martino MC; Galdiero M; Ciccarelli A; D'Errico A; Kourides I; Burman P; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):476-82. PubMed ID: 17105844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential markers of disease behavior in acromegaly and gigantism.
    Hernández-Ramírez LC
    Expert Rev Endocrinol Metab; 2020 May; 15(3):171-183. PubMed ID: 32372673
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
    Puder JJ; Nilavar S; Post KD; Freda PU
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1972-8. PubMed ID: 15634715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of disease duration on coronary calcification in patients with acromegaly.
    Herrmann BL; Severing M; Schmermund A; Berg C; Budde T; Erbel R; Mann K
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):417-22. PubMed ID: 19373755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acromegalic cardiomyopathy].
    Bencze A; Rácz K
    Orv Hetil; 2011 Nov; 152(47):1875-8. PubMed ID: 22042313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
    Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
    Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
    Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
    Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.
    Mercado M; Espinosa de los Monteros AL; Sosa E; Cheng S; Mendoza V; Hernández I; Sandoval C; Guinto G; Molina M
    Horm Res; 2004; 62(6):293-9. PubMed ID: 15542931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index.
    Baykan M; Erem C; Gedikli O; Hacihasanoğlu A; Erdoğan T; Koçak M; Kaplan S; Kiriş A; Celik S
    Echocardiography; 2008 Apr; 25(4):374-80. PubMed ID: 18177382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone status predicts left ventricular mass in patients after cure of acromegaly.
    Wexler TL; Durst R; McCarty D; Picard MH; Gunnell L; Omer Z; Fazeli P; Miller KK; Klibanski A
    Growth Horm IGF Res; 2010 Oct; 20(5):333-7. PubMed ID: 20598930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.